Addictions represent a major public health problem in developing countries, with health, economic and socio-professional impacts. The consumption of psychoactive drugs is responsible in France for more than 100,000 preventable deaths per year [1]. Data from epidemiological surveys on the gravity of the situation in sub-Saharan Africa are essentially hospital-based and not very representative of reality, because there are few services specializing in addictions. Opioid analgesics are molecules whose addictogenic potential has been known and described for many years [2]. In Cameroon, non-morphine analgesics are widely prescribed for the treatment of pain. Addiction to long-term use of non-opioid analgesics remains anecdotal in the scientific literature. We report here a rare case of addiction to Nefopam, a non-opioid analgesic, in a 45-year-old black woman with fibromyalgia. The aim of this presentation is to draw the attention of clinicians to the risk of addiction linked to the misuse of nefopam.

The most common site of ocular metastasis is the choroid. We report two cases of choroidal metastases (CM) revealing lung cancer. The first case is a 66-year-old patient consulting for reduced visual acuity. The fundus reveals a posterior pole choroidal mass. Ultrasound shows a weakly hyperhecogenic choroidal mass. Chest CT revealed the primary lung tumor. The second case is a 62-year-old woman consulting for reduced visual acuity in whom the fundus found a choroidal mass with sero-retinal detachment opposite. Fluorescein angiography, OCT, and ultrasound were in favor of choroidal metastasis. The lung CT scan revealed a lung tumor. Although uncommon, CM can be the initial manifestation of lung cancer. Their diagnosis is based on a range of clinical and paraclinical arguments. The treatment of CM with chemotherapy combined or not with ocular radiotherapy is often effective in disabling eye disorders. The aim of this work is to summarize the current knowledge on choroidal metastases, with an emphasis on epidemiology, diagnosis and treatment.

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) accounts for lessthan 1% of all Lymphomas that manifest themselves with sub cutaneous nodes, SPTCL may be associated to a systemic disease. We report in this paper the first case described in our department of a 57 years old female patient followed up for 5 years for a Subcutaneous panniculitis-like T-cell lymphoma, treated with dermocorticosteroids after 4 years of therapeutic abstention and who developed a Systemic lupus erythematosus for which she was put under treatment with a very good evolution.